IsomAb
Developer of antibodies to treat diabetic peripheral arterial disease.
1
Funding Rounds
$9.5m
Money raised
Overview
Developer of antibodies to treat diabetic peripheral arterial disease.
- Website:
- Headquarters: Nottingham
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company IsomAb has raised a total of $9.5m in funding over 1 rounds.
Key Insights:
- IsomAb February 2024 Seed Funding Round: $9.5m
IsomAb February 2024 Seed Funding Round
$9.5m